Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd share price and stock overview

Bafna Pharmaceuticals Ltd (NSE: BAFNAPH, BSE: 532989) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE878I01022 and a face value of Rs 10. As of 01 October 2026, it trades at Rs (371.35) with a market capitalisation of Rs 875.99 crore. Figures are live and subject to change.

Bafna Pharmaceuticals Ltd

Pharmaceuticals - Indian - Formulations
NSE BSE
371.35 7.20 (1.98%) upARrowC
As on: 01-Oct-2026 , 03:30 AM
Market Cap(₹Cr) 875.99
Book Value(₹Cr) 40.6443073
BSE Code : 532989 NSE Symbol : BAFNAPH EPS(TTM) : 3.29 ISIN Demat : INE878I01022 P/E(TTM) : 112.55 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

73,062.23

Todday's Low

72,366.44

Open at

72,441.15

Previous Close

72,529.07

Volumes

Avg Price

-48.78

Historical Performance

News

26 Sep 26
Bafna Pharmaceuticals halts trading for insiders pending quarterly results declaration
BAFNA PHARMACEUTICALS LIMITED will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
13 Aug 26
Bafna Pharmaceuticals schedules its 31st Annual General Meeting for September 11, 2026, via video conference
BAFNA PHARMACEUTICALS LIMITED will hold its 31st Annual General Meeting on Friday, September 11, 2026, at 10:00 A.
05 Aug 26
BAFNA Pharmaceuticals to review quarterly results at board meeting on August 11, 2026
BAFNA PHARMACEUTICALS LIMITED will hold a board meeting on August 11, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, and the trading window for designated persons and their immediate relatives will remain closed from July 1, 2026, to August 13, 2026.
30 May 26
Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter
Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
30-09-26 371.40 371.40 371.35 371.35 546 9 202783.60 22620.45
29-09-26 364.15 364.15 364.15 364.15 4801 27 1748284.15 22716.20
28-09-26 357.05 357.05 357.05 357.05 1073 19 383114.65 22780.25
25-09-26 350.05 350.05 350.05 350.05 2166 30 758208.30 23140.50
24-09-26 343.20 343.20 343.20 343.20 740 15 253968.00 23063.10
23-09-26 336.50 336.50 336.50 336.50 579 10 194833.50 23446.80
22-09-26 329.95 329.95 329.95 329.95 525 10 173223.75 23329.00
21-09-26 323.50 323.50 323.50 323.50 424 15 137164.00 23414.30
18-09-26 317.20 317.20 317.20 317.20 6714 19 2129680.80 23346.40
17-09-26 315.00 315.15 310.00 311.00 12918 52 4017875.65 23270.60
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

875.99

PE Ratio

112.55

PB Ratio

9.11

Dividend Yield

0

ROE

8.67

ROCE

8.91

Book Value (₹)

40.6443073

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 17640016 74.57 17640016 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 1989 0.01 1989 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100246 0.42 100246 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17742251 75.00 17742251 7
Total ShareHolding for Promoter & Group 17742251 75.00 17742251 7
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2209803 9.34 2209803 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2209803 9.34 2209803 3
plus  Non Institution
Bodies Corporate 593284 2.51 592784 54
Clearing Members 0 0.00 0 0
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 128675 0.54 128675 70
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 147997 0.63 147997 214
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1653549 6.99 1653549 13
Individuals holding nominal share capital up to Rs. 1 lakh 1178611 4.98 1172071 6696
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2137 0.01 2137 1
Sub Total 3704281 15.66 3697241 7052
Total Public Shareholding 5914084 25.00 5907044 7055
Total of Promoter & Public ShareHolding 23656335 100.00 23649295 7062
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 23656335 100.00 23649295 7062

Financials (₹ in cr)

Consolidated Standalone
No Data Available

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 23.6623.6623.6623.6623.6623.66
Reserves Total 72.4961.1557.1849.8038.3133.11
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds96.1584.8180.8473.4661.9756.77
Secured Loans 35.6326.7022.8921.429.042.50
Unsecured Loans 1.801.501.501.512.0212.79
Total Debt37.4328.2024.3922.9311.0615.29
Other Liabilities4.412.392.011.220.850.10
Total Liabilities137.99115.40107.2497.6173.8872.16
APPLICATION OF FUNDS :
Gross Block 134.28105.5399.4994.6687.9479.57
Less : Accumulated Depreciation 52.4946.7559.2854.4349.0943.60
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 81.7958.7840.2140.2338.8535.97
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress3.137.3112.271.500.000.83
Producing Properties0.000.000.000.000.000.00
Investments 0.000.000.000.000.000.00
Current Assets, Loans & Advances
Inventories 28.9028.0929.6422.2220.2815.44
Sundry Debtors 43.9340.1745.3941.1514.789.56
Cash and Bank Balance2.023.431.407.810.171.80
Loans and Advances 14.8013.0417.3416.1315.6522.86
Total Current Assets89.6584.7393.7787.3150.8849.67
Less : Current Liabilities and Provisions
Current Liabilities 36.0536.3039.1830.7314.7114.31
Provisions 1.481.381.261.261.560.00
Total Current Liabilities & Provisions37.5437.6840.4531.9916.2714.31
Net Current Assets52.1147.0553.3255.3334.6135.36
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability0.000.000.000.000.000.00
Net Deferred Tax0.000.000.000.000.000.00
Other Assets0.962.261.430.540.420.00
Total Assets137.99115.40107.2397.6073.8872.16
Contingent Liabilities20.2417.3317.5410.486.172.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -4.8110.18-0.851.065.62
Investing Activities -6.54-7.49-15.05-21.16-22.40
Net Cash Flow -1.637.64-6.412.04-1.41
Operating Activities 9.734.959.4822.1415.37

Peers

Balance Sheet Financial Ratios Profit & Loss
Accretion Nutrav...

Adline Chem Lab ...

Ajanta Pharma Lt...

3,620.80

(+1.78%)
Amrutanjan Healt...

514.75

(+1.88%)
BDH Industries L...

Bharat Immunolog...

Bharat Parentera...

1,792.80

(-6.92%)
Bio Medica Labor...

164.00

(+5.57%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Functional Directors
SH
Shanmugam Hemalatha
E D & Wholetime Director
Dir.
Independent Directors
ACR
Akilapriya Chandrashekar Raju
Non-Exec & Non-Independent Dir
Ind.
UMR
Upendar Mekala Reddy
Non-Exec & Non-Independent Dir
Ind.
PKS
Palamadai Krishnan Sundaresan
Independent Director
Ind.
Other Officials
RC
Ravichandran Chitra
Chairperson
Board
VDD
Vinayak Dinesh Dendukuri
ED / WTD - Quality
Board
AM
A Mohanachandran
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Bafna Pharmaceuticals Ltd? −

Bafna Pharmaceuticals Ltd trades on NSE under BAFNAPH and on BSE under code 532989. The ISIN is INE878I01022 and the face value is Rs 10.

What is the share price of Bafna Pharmaceuticals Ltd today? +

As of 01 October 2026, Bafna Pharmaceuticals Ltd trades at Rs 371.35, a change of 7.20 (1.98%) on the day. Prices are live and subject to change.

What is the market capitalisation of Bafna Pharmaceuticals Ltd? +

As of 01 October 2026, Bafna Pharmaceuticals Ltd has a market cap of about Rs 875.99 crore. This figure is live and moves with the share price.

Is Bafna Pharmaceuticals Ltd profitable? +

In , Bafna Pharmaceuticals Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Bafna Pharmaceuticals Ltd? +

: As of 01 October 2026, the PE (TTM) for Bafna Pharmaceuticals Ltd is 112.55 and the price-to-book ratio is 9.11. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Bafna Pharmaceuticals Ltd pay a dividend? +

As of 01 October 2026, the dividend yield for Bafna Pharmaceuticals Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Bafna Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 75.00% of Bafna Pharmaceuticals Ltd. Public shareholding is 25.00%, including mutual funds at 0.00% and foreign institutional investors at 9.34%.

What were the latest annual financials of Bafna Pharmaceuticals Ltd? +

In , Bafna Pharmaceuticals Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .